about
Avoiding Data Dumpsters — Toward Equitable and Useful Data SharingBest Practices for Ethical Sharing of Individual-Level Health Research Data From Low- and Middle-Income SettingsBeyond open data: realising the health benefits of sharing dataExperimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialTrust, Respect, and Reciprocity: Informing Culturally Appropriate Data-Sharing Practice in VietnamIntravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a randomized controlled trialThe policy of free healthcare for children under the age of 6 years in Vietnam: assessment of the uptake for children hospitalised with acute diarrhoea in Ho Chi Minh CityFeasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolIntensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated.A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patientsOrally active iron chelators.CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.Characterization of hospital and community-acquired respiratory syncytial virus in children with severe lower respiratory tract infections in Ho Chi Minh City, Vietnam, 2010.Thalassemia in Sri Lanka: a progress report.Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis.Clinical validation of a point-of-care multiplexed in vitro immunoassay using monoclonal antibodies (the MSD influenza test) in four hospitals in Vietnam.Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countriesClinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study.Hemoglobin E-beta-thalassemia: Progress report from the International Study Group.In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.An oral preparation of Lactobacillus acidophilus for the treatment of uncomplicated acute watery diarrhoea in Vietnamese children: study protocol for a multicentre, randomised, placebo-controlled trialGatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial.Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis.Lovastatin for adult patients with dengue: protocol for a randomised controlled trial.Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study.Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis.Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome.Haemoglobin E beta thalassaemia in Sri Lanka.A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.Open source clinical science for emerging infectionsCritically ill healthcare workers with the middle east respiratory syndrome (MERS): A multicenter studyFeatures of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
P50
Q24276671-95922721-98F0-4508-9C80-EF693E477B80Q24696013-40C68A34-7468-4EC5-A1D5-F19ABB379E2EQ27184819-80468363-5CBA-4DBA-B869-B9162C1567C4Q28551448-B80FF4B8-857A-4432-B01D-45693D748327Q28603482-2D3982B6-61B6-40B4-AA74-B5232B0312C9Q28604050-44688B9C-5830-4999-9E5E-5E2380901C97Q28659775-2A7699F9-47EA-4A50-9655-95575651DBBAQ30277992-1A7960DD-A49E-45CB-9665-B24E70F21A06Q30498213-07DE50F7-A205-4E2E-9761-CDB6E2A696C2Q33627682-DA596F2D-176D-4DC5-AA40-0DC5154479AEQ34288828-BFA75018-124F-4706-9291-4FCA9BE3B862Q34750544-1A4F7B6C-2A99-4961-ACD8-22BBD609D157Q34895613-DE5F707F-D3ED-4230-9765-E7F1550F5384Q35557357-F24A2DC0-1CDA-4E1A-B134-948AAC2692EFQ35883294-229DBB2D-B547-4783-A450-042088AC08D1Q35919786-460F05C5-6D3F-4967-995B-808581C5724EQ35942934-283A7954-7D52-46FA-B9C6-6002553596FBQ35954329-D67FE6A9-0F14-44D5-94B8-B5551D72BE84Q36166714-0CC2E19C-0354-4493-9D67-92F7AFF67E44Q36336972-BE9A3105-7781-4D8F-B5FF-7C844DE9DD12Q36418265-07FAEE96-FF09-49A6-968E-349B14B9FE8DQ36585052-1595D0B8-4293-4516-B8E6-886591F3D491Q36809586-05B6A8E0-D73E-445C-BFF3-9DC7028A0938Q37546645-756DB8D3-361B-406E-864B-556314A4FAC5Q38056781-8BD9A35A-E9AF-4205-ACB9-1157229321F9Q38634762-71E3DA03-7563-44DD-B4CE-556FCAF34232Q39062023-69DF0B57-E8A8-461A-B36A-9DCAC8AED04DQ39164655-BDEF9466-4E35-43A3-A27B-2662D7D0CA9FQ45073537-E8B38EF4-0524-4675-B075-6B17922A6A7DQ48017959-FEDD1C26-09AC-47A6-A2C0-72DDE9429CD7Q51747428-C912C402-6EB1-4B57-8421-EF3C3FF1A85DQ53678328-8220CD53-E7BF-4011-B061-ADEC0ACE53ACQ59804898-5C7A43AF-5900-4A9B-8E32-020B4DD09ACAQ95603683-F3F4EA91-751A-4C75-BA77-59327B10B112
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Laura Merson
@ast
Laura Merson
@en
Laura Merson
@es
Laura Merson
@nl
Laura Merson
@sl
type
label
Laura Merson
@ast
Laura Merson
@en
Laura Merson
@es
Laura Merson
@nl
Laura Merson
@sl
prefLabel
Laura Merson
@ast
Laura Merson
@en
Laura Merson
@es
Laura Merson
@nl
Laura Merson
@sl
P106
P1153
10639152700
P21
P31
P496
0000-0002-4168-1960